Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: We investigated the associations of morning and evening salivary cortisol levels with regional brain volumes and cognitive functioning in community-dwelling older persons without dementia.
Method: From the Age, Gene/Environment Susceptibility (AGES)–Reykjavik Study, we included 4,244 persons without dementia (age 76 ± 5 years, 58% women) who had 1.5T brain MRI, assessment of cognitive functioning, and saliva collected at home 45 minutes after awakening and at night. Linear regression analysis was used to estimate the cross-sectional relationship among cortisol levels, brain volumes, and cognitive functioning, adjusting for covariates.
Results: Higher evening cortisol was associated with smaller total brain volume (highest vs lowest tertile −16.0 mL; 95% confidence interval −19.7 to −12.2 mL, adjusted for age, sex, education, intracranial volume, smoking, steroid use, white matter lesions, and brain infarcts on MRI). The smaller volumes were observed in all brain regions, but were significantly smaller in gray matter than in white matter regions. Poorer cognitive functioning across all domains was also associated with higher evening cortisol. Higher levels of morning cortisol were associated with slightly greater normal white matter volume and better processing speed and executive functioning, but not with gray matter volume or with memory performance.
Conclusions: In older persons, evening and morning cortisol levels may be differentially associated with tissue volume in gray and white matter structures and cognitive function. Understanding these differential associations may aid in developing strategies to reduce the effects of hypothalamic-pituitary-adrenal axis dysfunction on late-life cognitive impairment.
GLOSSARY
- AD=
- Alzheimer disease;
- AGES–Reykjavik Study=
- Age, Gene/Environment Susceptibility–Reykjavik Study;
- BMI=
- body mass index;
- CI=
- confidence interval;
- DSST=
- Digit Symbol Substitution test;
- FA=
- flip angle;
- FLAIR=
- fluid-attenuated inversion recovery;
- FOV=
- field of view;
- HPA=
- hypothalamic-pituitary-adrenal;
- ICV=
- intracranial volume;
- MMSE=
- Mini-Mental State Examination;
- TE=
- time to echo;
- TR=
- repetition time;
- WML=
- white matter lesions
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received February 6, 2015.
- Accepted in final form May 18, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Circulating cortisol and cognitive and structural brain measuresThe Framingham Heart StudyJustin B. Echouffo-Tcheugui, Sarah C. Conner, Jayandra J. Himali et al.Neurology, October 24, 2018 -
Articles
Postmenopausal hormone therapy and regional brain volumesThe WHIMS-MRI StudyS. M. Resnick, M. A. Espeland, S. A. Jaramillo et al.Neurology, January 12, 2009 -
Article
Change in brain and lesion volumes after CEE therapiesThe WHIMS-MRI studiesLaura H. Coker, Mark A. Espeland, Patricia E. Hogan et al.Neurology, January 02, 2014 -
Article
Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophyM. Grundman, J. Corey-Bloom, T. Jernigan et al.Neurology, June 01, 1996